As of 2025-09-16, the Relative Valuation of Hollister Biosciences Inc (HOLL.CN) is 0.00 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.15 CAD, the upside of Hollister Biosciences Inc based on Relative Valuation is -96.8%.
The range of the Relative Valuation is 0.00 - 0.03 CAD.
| Range | Selected | |
| Trailing P/E multiples | 0.3x - 2.1x | 0.3x |
| Forward P/E multiples | 0.3x - 2.1x | 0.3x |
| Fair Price | 0.00 - 0.03 | 0.00 |
| Upside | -97.3% - -77.4% | -96.8% |
| Date | P/E |